EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation

Alisa W Serio, Tiffany Keepers, Logan Andrews, Kevin M Krause

EcoSal Plus · 31.12.2018 · 8 (1)

DOI: 10.1128/ecosalplus.esp-0002-2018 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EcoSal Plus, erschienen am 31.12.2018. Verfasst von Alisa W Serio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Achaogen Inc., South San Francisco, CA 94080. Die Arbeit wurde bisher 168-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aminoglycosides are cidal inhibitors of bacterial protein synthesis that have been utilized for the treatment of serious bacterial infections for almost 80 years. There have been approximately 15 members of this class approved worldwide for the treatment of a variety of infections, many serious and life threatening. While aminoglycoside use declined due to the introduction of other antibiotic classes such as cephalosporins, fluoroquinolones, and carbapenems, there has been a resurgence of interest in the class as multidrug-resistant pathogens have spread globally. Furthermore, aminoglycosides are recommended as part of combination therapy for empiric treatment of certain difficult-to-treat infections. The development of semisynthetic aminoglycosides designed to overcome common aminoglycoside resistance mechanisms, and the shift to once-daily dosing, has spurred renewed interest in the class. Plazomicin is the first new aminoglycoside to be approved by the FDA in nearly 40 years, marking the successful start of a new campaign to rejuvenate the class.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminoglycosidesAnti-Bacterial AgentsBacterial InfectionsDrug Therapy, CombinationHumansMicrobial Sensitivity TestsProtein Synthesis InhibitorsSisomicin

Substanzen

AminoglycosidesAnti-Bacterial AgentsProtein Synthesis InhibitorsplazomicinSisomicin

Autor:innen und Institutionen

  • Achaogen Inc., South San Francisco, CA 94080.

Zitieren

APA

Serio, A. W., Keepers, T., Andrews, L., & Krause, K. M. (2018). Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation. EcoSal Plus, 8(1). https://doi.org/10.1128/ecosalplus.esp-0002-2018

Vancouver

Serio AW, Keepers T, Andrews L, Krause KM. Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation. EcoSal Plus. 2018;8(1). doi:10.1128/ecosalplus.esp-0002-2018

BibTeX
@article{Serio2018,
  author = {Serio, Alisa W and Keepers, Tiffany and Andrews, Logan and Krause, Kevin M},
  title = {Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation},
  journal = {EcoSal Plus},
  year = {2018},
  volume = {8},
  number = {1},
  doi = {10.1128/ecosalplus.esp-0002-2018}
}
Kostenlos starten →